Laplace Interventional Inc. Announces $7.9M Series A For Its Transcatheter Tricuspid Valve Technology
Round Type
Series A
PlymouthBiotechnologyHealth CareMedicalMedical DeviceDescription
Minnesota based Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, announced today that it has closed on its Series A financing led by a non-disclosed major strategic investor along with a significant investment from ShangBay Capital, an early stage medical device investor as well as other investors including Mayo Clinic. The $7.9M Series A financing round will fund Laplace Interventional towards achieving its preclinical milestones. The company also announced the addition of two Directors to its Board including William Dai, Founding Managing Partner at ShangBay Capital.
Quick answer
Laplace Interventional raised an undisclosed amount in a Series A round, dated September 2, 2021. Laplace Interventional is based in Plymouth, Minnesota, United States.
- How much did Laplace Interventional raise?
- Laplace Interventional raised an undisclosed amount in a Series A round on September 2, 2021.
- What does Laplace Interventional do?
- Laplace Interventional is developing a minimally invasive transcatheter treatment for patients suffering from Tricuspid Regurgitation.
- Where is Laplace Interventional based and how big is it?
- Laplace Interventional is based in Plymouth, Minnesota, United States. Fundz records about 10 employees.
- Who are the decision-makers at Laplace Interventional?
- Fundz holds 2 contacts at Laplace Interventional. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Laplace Interventional that raised within 45 days of this round, from Fundz verified event records.
- WaveFront Dynamics Inc. raised $700K (Seed) on October 14, 2021.
- Nusano raised $48M on September 23, 2021.
- Neochord raised $1M (Seed) on September 20, 2021.
- SPR Therapeutics raised $20M on August 31, 2021.
- Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.
- Sanara MedTech raised $500K (Seed) on July 27, 2021.
Who to call at Laplace Interventional, and when
A new round usually means Laplace Interventional is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Laplace Interventional raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Laplace Interventional, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Laplace Interventional. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Laplace Interventional raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLaplace Interventional raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.